NYSE
XYL
Last Price
US $118.12
KEY FIGURES
MKT CAP
$27.7B
EPS
TTM
$4.01
PEG
TTM
3.73x
P/E
TTM
28.97x
P/S
TTM
3.06x
YIELD
1.43%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial stability - Cash flow debt coverage.
Xylem Inc. cash flow to debt ratio of 60.16% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Financial risk - Healthy cash flow growth.
Xylem Inc.'s free cash flow has decreased -3.40% from $942.00M last year to $910.00M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Xylem Inc.'s debt to equity ratio is 0.19, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Xylem Inc.'s debt has decreased relative to shareholder equity from 0.20 last year to 0.19 today, signaling strengthened financials
Financial stability - Net debt/EBITDA.
Xylem Inc. has a net debt to EBITDA ratio of 0.33x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Financial stability - ICR.
Xylem Inc.'s interest coverage ratio of 49.44 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Xylem Inc.'s profit margin has increased (2.96%) in the last year from 10.39% to 10.70%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Xylem Inc.'s short-term assets of $4.64G exceed its short-term liabilities of $2.86G
Increasing performance - ROA.
Xylem Inc.'s return on assets of 5.74% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
Xylem Inc.'s return on equity of 8.70%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Xylem Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Xylem Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Xylem Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Xylem Inc. has a free cash flow yield of 3.29%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Increasing performance - Healthy earnings growth.
Xylem Inc.'s yearly earnings has increased 7.53% since last year from $890.00M to $957.00M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Xylem Inc.'s yearly revenue has increased 5.52% since last year from $8.56G to $9.04G, signaling increasing performance
Increasing performance - ROIC.
ROIC 6.70% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Xylem Inc.'s 3-year revenue CAGR of 17.84% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Xylem Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Xylem Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Xylem Inc. is overvalued relative to its fair value price of 57.53 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Xylem Inc. has an earnings yield of 3.44%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Xylem Inc. is overvalued relative to its fair value price of 49.49 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Xylem Inc. has an EV/EBITDA ratio of 16.06x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Xylem Inc. has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
Xylem Inc. has a price-to-book ratio of 2.58x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Xylem Inc. has a price-to-sales ratio of 3.04x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
8.70%
Return on equity
ROIC: 6.70%
Valuation History
29.0X
Price to Earnings
EV/EBITDA: 16.1X
Cash flow
Profit margin
13.13%
(FY vs FY)
EBITDA Y/Y
23.83%
(FY vs FY)
Cash flow Y/Y
7.26%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $118.12
-51.30%
Default assumptions
EBITDA Multiple
Fair Value
Market $118.12
-58.10%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.